FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With ... (lex concentrates(aPCCs) to resolve bleed...)

HOME >> MEDICINE >> NEWS

FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors

Date:5/13/2008

lex concentrates (aPCCs), to resolve bleeds. Patients with lower responding inhibitors may be treated with high doses of either Factor VIII or Factor IX to stop bleeding.

About NovoSeven(R) RT and NovoSeven(R)

NovoSeven(R) RT and NovoSeven(R) are indicated for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors to FVIII or FIX and in patients with acquired hemophilia; prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B patients with inhibitors to FVIII or FIX and in patients with acquired hemophilia; treatment of bleeding episodes in patients with congenital FVII deficiency and prevention of bleeding in surgical interventions or invasive procedures in patients with congenital FVII deficiency.

For prescribing information, please visit NovoSevenRT.com.

Important Safety Information:

NovoSeven(R) was studied in 298 patients with hemophilia A or B with inhibitors treated for 1939 bleeding episodes. The most common side effects in people taking NovoSeven(R) were fever, bleeding, a decrease in the amount of coagulation factor 1, pain from blood collecting in a joint, and high blood pressure. People who have ever had a bad reaction to proteins from mice, hamsters, or "bovines" (such as an ox or cow) should not be treated with NovoSeven(R). After taking NovoSeven(R), some patients have more of a risk of thrombosis, which is when a clot forms in a blood vessel and causes harm. Although the extent of this risk is not known, it is thought to be small. Some patients have conditions that may increase this risk. These include clogged arteries, blood clots that form throughout the body instead of at the place of injury, a type of blood poisoning called septicemia, and crush injury, which is when a body part is crushed or squeezed between heavy or immobile objects. Also, people taking aPCCs/PCCs (activated or nonactivated prothrombin complex concentrates) at the same time that th
'/>"/>

SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4
Related medicine news :

1. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
2. FDA Approves Health Claim for Brown Rice
3. FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
4. FDA approves HeartMate II mechanical heart pump for heart-failure patients
5. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
6. FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis
7. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
8. FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE
9. House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort
10. VeriPrime Approves New Best Practices for Beef Production
11. U.S. EPA Approves Registration of Antimicrobial Copper Alloys

Post Your Comments:

(Date:12/17/2009)... Physicians Healthcare Management Group, Inc. (Phyhealth) ... it has issued its financial statements for the ... are being posted today on the Pink Sheets ... Management Group, Inc. ,, Physicians Healthcare ... community-based health maintenance organizations (HMOs) that are owned ...

(Date:12/17/2009)... characteristics involved in the exposure of pregnant women to ... standing up or have to lift heavy objects, 63% ... are frequently exposed to some physical risk in their ... especially sensitive to exposure to workplace hazards", M Carmen ... at the Higher Centre for Public Health Research in ...

(Date:12/17/2009)... Stem cells that could one day provide therapeutic ... harvested from the tissue of the umbilical cord, just ... cells to treat some blood disorders, said University of ... version of the Journal of Biomedicine and ... be expanded to greater number, are remarkably stable and ...

(Date:12/17/2009)... Science in Human Resource Development Degree Online , ... ... Open enrollment has begun for Villanova’s newly online HR ... whose busy schedules can’t accommodate a campus-based program. With the ... in March 2010, location is no longer a barrier to ...

(Date:12/17/2009)... -- CareFusion Corporation (NYSE: CFN ) announced ... mini-tender offer by TRC Capital Corporation (TRC) to purchase ... representing approximately 1.8 percent of the shares of common ... is 4.62 percent below the share closing price of ... full trading day prior to the offer. CareFusion also ...

Breaking Medicine News(10 mins):Health News:Phyhealth Issues September 30, 2009 Financial Statements 2 Health News:Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work 2 Health News:Umbilical cord could be new source of plentiful stem cells, say Pitt researchers 2 Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 2 Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 3 Health News:CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital 2

[0] Phyhealth Issues September 30, 2009 Financial Statements [0] Almost two-thirds of pregnant women believe they are regularly exposed to physical risk at work [0] Umbilical cord could be new source of plentiful stem cells, say Pitt researchers [0] A World-Class HR Master's Degree Is Now Within Reach – 100% Online [0] CareFusion Recommends Rejection of Mini-Tender Offer by TRC Capital

... track record in supporting clinical trials, most notably in ... Phase I/II clinical testing center at the Walter Reed ... CRM is the premier clinical research organization supporting this ... capabilities, it looked to the National Institute of Allergy ...

... skyrocket over the next five ... according to Millennium Research Group, WALTHAM, Mass., Aug. ... for Women,s Health Imaging Systems 2008 report,the market for ... (MRI) coils, dedicated breast MRI systems, and,breast-specific gamma imaging ...

... Toledo Children,s Hospital and Good Samaritan Hospital, ... NORTH HOLLYWOOD, Calif., Aug. 7 IPC The,Hospitalist ... national hospitalist,physician group practice company, announced today that ... Hospital in Toledo,Ohio and Good Samaritan Hospital in ...

... reported financial results for the three and six months ended June ... ... EON) August 7, 2008 -- Total revenue for the three ... million, respectively, as compared to $496,000 and $999,000, respectively, for the ...

... Aug. 7 Micromet, Inc. (Nasdaq:,MITI), a biopharmaceutical ... for the treatment of cancer, inflammation and,autoimmune diseases, ... and six months ended June 30, 2008., ... and MedImmune presented a clinical update for the,BiTE(R) ...

... to $9.6 million from $4.9 million -, LISLE, ... or the "Company") (NASDAQ: SXCI , TSX: SXC), ... ended June 30, 2008. Financial,references are in U.S. dollars ... National Medical Health Card Systems,Inc. ("NMHC") on April 30, ...

Clinical Research Management gets contract for trials of therapeutics against infectious diseases Adjunct Breast Imaging Market to Increase by Almost 28% per Year Through 2013 IPC The Hospitalist Company Enters Ohio and Pennsylvania Markets Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results Micromet, Inc. Reports Second Quarter 2008 Financial Results SXC Health Solutions announces second quarter financial results

(Date:12/16/2009)... YORK, December 16 International, ... publication of GFT505 (80 mg/day),data presented ... internationally,recognized expert scientists and clinicians critically ... continuing role of generic lipid-modifying,treatments, fenofibrate ... is commonly observed in patients with ...

(Date:12/16/2009)... 16 Boston Scientific Corporation (NYSE: ... Directors has elected Nelda Connors as a Director. ... Electrical and Metal Products division of Tyco International. ... holding several positions in operations and general management. ... number of executive and management capacities with Ford, Chrysler ...

(Date:12/16/2009)... Wash., Dec. 16 Verathon®, maker ... to announce that portable bladder volume ultrasound ... CDC guidelines for the Prevention of Catheter-Associated ... CDC guidelines, introduced in early November 2009, ... to 1981. The guidelines are located ...

Breaking Medicine Technology:International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2 International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3 Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 2 Boston Scientific Announces Election of Nelda Connors to Its Board of Directors 3 New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 2 New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 3 New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 4 New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 5 Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice 13071 1 Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice 13071 2 How To Reduce Cost Without Sacrificing Your Health Coverage 51954 1 How To Reduce Cost Without Sacrificing Your Health Coverage 51954 2 Many Veterans Need Mental Health Care 51950 1 Many Veterans Need Mental Health Care 51950 2 Many Veterans Need Mental Health Care 51950 3 Many Veterans Need Mental Health Care 51950 4

[0] International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia [0] Boston Scientific Announces Election of Nelda Connors to Its Board of Directors [0] New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound

... PBT2 Alters Biomarkers and Rapidly Improves Cognition ... Australia - June 7, 2007 - Prana ... biopharmaceutical company,focused on the research and development ... it will present,new data on Prana's lead ...

... 07, 2007 /PRNewswire-FirstCall/ --,NeurogesX, Inc. announced today the ... trial in postherpetic neuralgia (PHN).,Misha-Miroslav Backonja, M.D., Professor ... lead academic investigator in the,NeurogesX trial, plans to ... 8 poster session at the Second International Congress ...

Other Medicine Technology:Prana Biotechnology Presents New Key Findings on PBT2 2 Prana Biotechnology Presents New Key Findings on PBT2 3 Prana Biotechnology Presents New Key Findings on PBT2 4 Prana Biotechnology Presents New Key Findings on PBT2 5 NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 2 NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 3 NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG) 4

Prana Biotechnology Presents New Key Findings on PBT2 NeurogesX Announces Presentation of Positive Phase 3 Clinical Data,at the Second International Congress on Neuropathic Pain Meeting,(NeuPSIG)

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Alanine Aminotransferase, Serum or Plasma Al, Plasma AFP-L3%AFP (Tumor Marker)

FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With ...(lex concentrates(aPCCs) to resolve bleed...),Health